Aripiprazole versus other atypical antipsychotics for schizophrenia

Keyphrases

• Schizophrenia 100%
• Randomized Clinical Trial 100%
• Atypical Antipsychotics 100%
• Aripiprazole 100%
• Confidence Interval 33%
• Risk Ratio 25%
• No Significant Difference 20%
• Mental States 20%
• Service Use 20%
• Global State 20%
• General Functioning 20%
• Clinical Trial Risk 20%
• Quality of Life 16%
• Risperidone 16%
• Olanzapine 12%
• People with Schizophrenia 12%
• Quetiapine 12%
• Extrapyramidal Symptoms 12%
• Ziprasidone 12%
• Quality of Service 8%
• Between-group 8%
• Random Effects Model 8%
• PANSS 8%
• Schizophrenia Spectrum Disorders 8%
• Clozapine 8%
• WHOQOL 8%
• General Service 8%
• Adverse Effects 4%
• Search Methods 4%
• Extracted Data 4%
• Developed Countries 4%
• Selection Criteria 4%
• Drug Treatment 4%
• First-line Drugs 4%
• Weight Gain 4%
• Pharmaceutical Companies 4%
• Number of Participants 4%
• Clinically Significant 4%
• Continuous Data 4%
• Cochrane 4%
• Risk of Bias 4%
• Dichotomous Data 4%
• Amisulpride 4%
• Antipsychotics 4%
• Calculated Risk 4%
• Comparative Risk 4%
• Positive Symptoms 4%
• Intention-to-treat 4%
• Drug Approval 4%
• GRADE Approach 4%
• Tolerability 4%
• Quality of Life Assessment 4%
• Second-generation Antipsychotics 4%
• Sertindole 4%
• Pragmatic Trial 4%
• Clozapine Olanzapine 4%
• Adverse Effect Profile 4%
• Zotepine 4%

Neuroscience

• Atypical Antipsychotic 100%
• Dementia Praecox 100%
• Aripiprazole 100%
• Risperidone 36%
• Olanzapine 36%
• Quetiapine 27%
• Clozapine 27%
• Ziprasidone 27%
• Extrapyramidal Symptoms 27%
• Adverse Effect 18%
• Typical Antipsychotic 18%
• Amisulpride 9%
• Positive Syndrome 9%
• Zotepine 9%
• Sertindole 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Clinical Trial 100%
• Atypical Antipsychotics 100%
• Aripiprazole 100%
• Risperidone 16%
• Olanzapine 16%
• Quetiapine 12%
• Clozapine 12%
• Extrapyramidal Symptoms 12%
• Ziprasidone 12%
• Symptom 8%
• Adverse Event 8%
• Random Effects Model 8%
• Typical Antipsychotic 8%
• Pharmacotherapy 4%
• Amisulpride 4%
• Antipsychotic 4%
• Positive Syndrome 4%
• Group Trial 4%
• Drug Approval 4%
• Tolerability 4%
• Zotepine 4%
• Sertindole 4%